Tag Archives: melanoma

December, 2018

November, 2018

October, 2018

August, 2018

June, 2018

May, 2018

  • 31 May

    Syndax and Nektar Therapeutics Partner for Immuno-Oncology Clinical Trial

    WALTHAM, Mass. and SAN FRANCISCO, May 30, 2018 /PRNewswire/ — Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, and Nektar Therapeutics (Nasdaq: NKTR) today announced a non-exclusive, clinical collaboration to evaluate the safety and efficacy of Nektar’s NKTR-214, a CD122-biased agonist, …